Signatur Biosciences is a biotech company that offers bringing molecular diagnostics services for cancer patients.
Signatur Biosciences has raised $7.0M in total funding. The most recent round was Seed. The last funding was announced in April 2025.
Signatur Biosciences's investors include Y Combinator, Ion Beam Applications, Noshaq.
Signatur Biosciences is headquartered in New York, United States.
Signatur Biosciences is a biotech company that offers bringing molecular diagnostics services for cancer patients.
Signatur Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Signatur Biosciences — Funding & Investors." VCBacked, April 28, 2025, https://www.vcbacked.co/company/signatur-biosciences. Accessed September 14, 2026.
VCBacked. (2025). Signatur Biosciences — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/signatur-biosciences
{{cite web |title=Signatur Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/signatur-biosciences |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated